Thomas Dayspring (@drlipid) 's Twitter Profile
Thomas Dayspring

@drlipid

MD, FACP, FNLA - Clinical Lipidologist: Tweets/Re-Tweets do not represent endorsements/medical advice

ID: 56916619

calendar_today15-07-2009 03:50:32

20,20K Tweet

40,40K Followers

602 Following

Thomas Dayspring (@drlipid) 's Twitter Profile Photo

What an amazing editorial by Sniderman et al - sadly firewalled - "Incorporating apoB and Lp(a) into routine clinical care will improve assessment of CV risk due to the apoB lipoproteins. Adopting apoB as the primary measure of the effectiveness of therapy will radically

What an amazing editorial by Sniderman et al - sadly firewalled - "Incorporating apoB and Lp(a) into routine clinical care will improve assessment of CV risk due to the apoB lipoproteins. Adopting apoB as the primary measure of the effectiveness of therapy will radically